RxDoctor Payments DataLook up a doctor →

Rachel Cook

Acute Care · Birmingham, ALNPI 1831748094

Payments from drug & device makers

$9,778in general payments, 2019–2025

Across 443 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$1K
  • UCB, Inc.$1K
  • AstraZeneca$731
  • Lilly USA, LLC$503
  • Neurocrine Biosciences, Inc.$454
  • plus $4K from 38 others

What the payments were for

  • Speaking & faculty fees$190%
  • Food & beverage$9,759100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,778 in reported general payments places this provider in the 95th percentile of 711 acute care providers in Alabama.

See all acute care providers in Alabama

Medicare billing

Part B allowed, 2024
$4,469
Medicare patients
43
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole21$14,942
Atorvastatin Calcium15$285
Amlodipine Besylate26$268
Quetiapine Fumarate13$91
ClopidogrelClopidogrel Bisulfate11$85

Paid to pharmacies, not to this prescriber.

Other acute care in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →